Sequential Infusion of Anti-CD22 and Anti-CD19 Chimeric Antigen Receptor T Cells for a Pediatric Ph-Like B-ALL Patient That Relapsed After CART-Cell and Haplo-HSCT Therapy: A Case Report and Review of Literature [Corrigendum]

Hua J, Qian W, Wu X, et al. Onco Targets Ther. 2020;13:2311–2317.

The authors of this paper have advised that the author and affiliation list on page 2311 is incorrect. The correct author and affiliation list is as follows:

Jingsheng Hua^1,2,*

Weiqing Qian^3,*

Xiaoxia Wu^1,*

Lili Zhou¹

Lei Yu⁴

Suning Chen¹

Jian Zhang¹

Huiying Qiu¹

¹Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou 215006, Jiangsu, People’s Republic of China; ²Department of Hematology, Taizhou Municipal Hospital, Taizhou 318000, Zhejiang, People’s Republic of China; ³Suzhou Vocational Health College, Suzhou, Jiangsu, People’s Republic of China; ⁴College of Chemistry and Molecular Engineering, East China Normal University, Shanghai, People’s Republic of China

*These authors contributed equally to this work

The authors have also advised that the correspondence section on page 2311 is incorrect. The correspondence section should read as follows:

Correspondence: Huiying Qiu; Jian Zhang

Tel +8613912792913

Fax +8651267781850

Email qiuhuiying8303@suda.edu.cn; crystalzj06@163.com